Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Injectco vs Mevo Health

Injectco
Graded #241

Higher grade

vs+4.3999999999999915
Mevo Health
Graded #327

Lower grade

The verdict

Injectco takes it — 64.6/100 to 60.2/100.

Injectco grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Injectco is a Dallas-based medspa offering compounded GLP-1 prescriptions shipped from licensed US partner pharmacies.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueInjectco +16
72
56
Dose & formulationMevo Health +19
64
83
Clinical oversightInjectco +4
71
67
Labs & monitoringInjectco +1
53
52
FulfillmentInjectco +3
60
57
Contract termsInjectco +35
55
20
Injectco · left barMevo Health · right bar

The numbers

MetricInjectcoMevo Health
WeighScore64.6/10060.2/100
GradeCC
Scorecard rank#241#327
Semaglutide$156/mo (compounded)$199/mo (all doses, compounded)
Tirzepatide$425/mo (starting dose, compounded)$259/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Injectco

Graded #241 · C

Strengths

  • Physical address in Dallas TX
  • Founded July 2021 — established
  • Bulk pricing ($1,249 for 6-8 months) can be cost-effective
  • Payment plan available ($156/mo)

Where it loses points

  • Does not specify which GLP-1 drug (semaglutide vs tirzepatide)
  • No LegitScript or PCAB accreditation
  • Primarily a medspa (Botox, fillers, hair restoration)
  • May be Texas-only — unclear if telehealth ships nationally
  • No named pharmacy partners
Mevo Health

Graded #327 · C

Strengths

  • LegitScript verification badge on multiple pages
  • Publishes the FDA compounded-medication disclaimer
  • Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
  • Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
  • Public entry-level pricing surfaced

Where it loses points

  • States served not listed on any public page
  • Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
  • No formal Medical Director role disclosed
  • Only 'as low as' entry pricing shown — no per-dose itemization
  • No SOC 2 certification claimed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard